AMSF

AMERISAFE is a disciplined, well-run specialist that underwrites workers' comp for hazardous industries (construction, trucking, logging, maritime), earning higher premiums for more-severe-but-less-frequent claims. The quality shows in the returns: ROE of 18.7% (management cites 18.5% on average equity for 2025), a strong balance sheet, and $61.9M cash (+40.6%). The stock is not expensive at a 14.2 P/E and 2.1 P/S, and the regular $2.56/share dividend is a ~7.3% yield on a $34.99 price — historically topped up with large specials ($4.48 in 2024, $4.86 in 2023). For an income-oriented investor this is a legitimate hold.

But the trend underneath the quality is decidedly downhill. Net income has fallen four of the last five years — $65.8M (2021) → $47.1M (2025), down 15% in the latest year and ~28% off the 2021 peak — while revenue has been dead flat around $310-317M. That is the classic soft phase of the cyclical workers'-comp market management flags as its first risk factor. Two engines are cooling at once: net investment income slipped to $27.0M (from $31.3M in 2023) and the favorable reserve development that flatters mature comp books is thinning, so margins are compressing (net margin 14.9%, ROE down from 20.4% in 2023). Tellingly, operating cash flow collapsed to $11.1M (-54%) and book value per share has actually shrunk to $13.39 from $15.28 in 2023 — because the company pays out essentially everything, growth in intrinsic value is minimal.